AMBFF.US Ambu A/S

Healthcare Biotechnology USA Stocks
14.48 USD
Close of Nov 13, 2026
9.40 13.82
Market cap
USD 3.28B
P/E
33.1x
P/B
3.51x
ROE
10.3%
Dividend yield
0.66%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2026.

Is AMBFF.US undervalued?

Graham number
Price14.48
Graham value6.37
Premium127.1%

AMBFF.US trades 127.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ambu A/S fundamental analysis

No fundamental analysis for Ambu A/S yet.

Ambu A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring pr…

Full company profile